Literature DB >> 10546024

Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients.

R Weitgasser1, F Schnoell, B Gappmayer, I Kartnig.   

Abstract

OBJECTIVE: To analyze prospectively the importance of urinary N-acetyl-beta-D-glucosaminidase (NAG), a marker for renal tubular function, in comparison with urinary albumin excretion (UAE), a marker for glomerular renal function, with respect to macrovascular disease in elderly patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We followed 124 patients over a mean period of 7.0 +/- 0.5 years. At baseline, urinary NAG, UAE, age, diabetes duration, sex, blood pressure, lipids, and serum creatinine were determined. Also, history of myocardial infarction (MI), stroke, severe peripheral vascular disease (PVD), antidiabetic and concomitant medication, and smoking habits were recorded. After 7 years, patients were reevaluated, and a multivariate logistic regression analysis was used to test risk factors for significance in order to predict macrovascular disease. Subgroups of patients were analyzed with respect to severe macrovascular disease, with a separate analysis for surviving patients.
RESULTS: Compared with known cardiovascular risk factors such as microalbuminuria and total cholesterol, urinary NAG was similarly associated with cardiovascular disease for the total cohort (P < 0.05). Analyzing the subgroup of 65 patients still alive after follow-up care, urinary NAG and UAE were significantly elevated at baseline and at the time of follow-up care in patients with MI and PVD, but not in those with stroke (P < 0.01). There was a positive predictive trend of NAG excretion for the development of MI and PVD in our patients (P = 0.07).
CONCLUSIONS: Urinary NAG proved comparable to UAE when analyzed with respect to preexistence and development of severe macrovascular disease. It needs to be determined by further studies if urinary NAG will be of value to serve as an adjunct marker to UAE in type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10546024     DOI: 10.2337/diacare.22.11.1882

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population.

Authors:  Marit D Solbu; Ingrid Toft; Maja-Lisa Løchen; Ellisiv B Mathiesen; Bjørn O Eriksen; Toralf Melsom; Inger Njølstad; Tom Wilsgaard; Trond G Jenssen
Journal:  J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 10.121

2.  Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.

Authors:  Noriko Satoh-Asahara; Takayoshi Suganami; Takafumi Majima; Kazuhiko Kotani; Yasuhisa Kato; Rika Araki; Kazunori Koyama; Taiichiro Okajima; Makito Tanabe; Mariko Oishi; Akihiro Himeno; Shigeo Kono; Akira Sugawara; Masakazu Hattori; Yoshihiro Ogawa; Akira Shimatsu
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

3.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors:  Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

Review 4.  Biomarkers in diabetic nephropathy: Present and future.

Authors:  Gemma Currie; Gerard McKay; Christian Delles
Journal:  World J Diabetes       Date:  2014-12-15

Review 5.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

6.  Serum N-acetyl-beta-D-glucosaminidase profiles in type 1 diabetes secondary complications: causes of changes and significance of determination.

Authors:  V B Jovanović; V S Dimitrijević-Srecković; Ljuba M Mandić
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

7.  Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.

Authors:  Motoshi Ouchi; Kenzo Oba; Taro Saigusa; Kentaro Watanabe; Makoto Ohara; Noriaki Matsumura; Tatsuya Suzuki; Naohiko Anzai; Shuichi Tsuruoka; Masahiro Yasutake
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-09       Impact factor: 3.738

8.  Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.

Authors:  So Ra Kim; Yong-Ho Lee; Sang-Guk Lee; Eun Seok Kang; Bong-Soo Cha; Jeong-Ho Kim; Byung-Wan Lee
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 9.  Diabetic nephropathy: What does the future hold?

Authors:  R M Montero; A Covic; L Gnudi; D Goldsmith
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370

10.  The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.

Authors:  So Ra Kim; Yong-Ho Lee; Sang-Guk Lee; Eun Seok Kang; Bong-Soo Cha; Byung-Wan Lee
Journal:  Cardiovasc Diabetol       Date:  2017-01-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.